| Complementary PET studies of striatal neuronal function in the differential diagnosis between multiple system atrophy and Parkinson's disease. A Antonini, KL Leenders, P Vontobel, RP Maguire, J Missimer, M Psylla, ... Brain: a journal of neurology 120 (12), 2187-2195, 1997 | 300 | 1997 |
| Complementary positron emission tomographic studies of the striatal dopaminergic system in Parkinson's disease A Antonini, P Vontobel, M Psylla, I Günther, PR Maguire, J Missimer, ... Archives of neurology 52 (12), 1183-1190, 1995 | 220 | 1995 |
| Synthesis and Nicotinic Acetylcholine Receptor in Vivo Binding Properties of 2-Fluoro-3-[2(S)-2-azetidinylmethoxy]pyridine: A New Positron Emission Tomography … F Dollé, L Dolci, H Valette, F Hinnen, F Vaufrey, I Guenther, C Fuseau, ... Journal of medicinal chemistry 42 (12), 2251-2259, 1999 | 158 | 1999 |
| Ga-66 labeled somatostatin analogue DOTA-DPhe1-Tyr3-octreotide as a potential agent for positron emission tomography imaging and receptor mediated internal radiotherapy of … Ö Ugur, PJ Kothari, RD Finn, P Zanzonico, S Ruan, I Guenther, ... Nuclear medicine and biology 29 (2), 147-157, 2002 | 155 | 2002 |
| Imaging brain tumor proliferative activity with [124I] iododeoxyuridine RG Blasberg, U Roelcke, R Weinreich, B Beattie, K von Ammon, ... Cancer Research 60 (3), 624-635, 2000 | 141 | 2000 |
| Synthesis of 2‐[18F]fluoro‐3‐[2(S)‐2‐azetidinylmethoxy]pyridine, a highly potent radioligand for in vivo imaging central nicotinic acetylcholine receptors F Dolle, H Valette, M Bottlaender, F Hinnen, F Vaufrey, I Guenther, ... Journal of Labelled Compounds and Radiopharmaceuticals 41 (5), 451-463, 1998 | 88 | 1998 |
| Imaging central nicotinic acetylcholine receptors in baboons with [18F] fluoro-A-85380 H Valette, M Bottlaender, F Dollé, I Guenther, C Fuseau, C Coulon, ... Journal of Nuclear Medicine 40 (8), 1374-1380, 1999 | 84 | 1999 |
| Benzodiazepine receptor binding in Huntington's disease: [11C]Flumazenil uptake measured using positron emission tomography G Künig, KL Leenders, R Sanchez‐Pernaute, A Antonini, P Vontobel, ... Annals of neurology 47 (5), 644-648, 2000 | 71 | 2000 |
| Quantitation of extrastriatal D2 receptors using a very high-affinity ligand (FLB 457) and the multi-injection approach J Delforge, M Bottlaender, C Loc'h, I Guenther, C Fuseau, B Bendriem, ... Journal of Cerebral Blood Flow & Metabolism 19 (5), 533-546, 1999 | 69 | 1999 |
| Nanodiamond–Manganese dual mode MRI contrast agents for enhanced liver tumor detection W Hou, TB Toh, LN Abdullah, TWZ Yvonne, KJ Lee, I Guenther, ... Nanomedicine: Nanotechnology, Biology and Medicine 13 (3), 783-793, 2017 | 58 | 2017 |
| Whole-body biodistribution and radiation dosimetry of the human cannabinoid type-1 receptor ligand 18F-MK-9470 in healthy subjects K Van Laere, M Koole, SMS Bohorquez, K Goffin, I Guenther, ... Journal of Nuclear Medicine 49 (3), 439-445, 2008 | 56 | 2008 |
| Synthesis and in vivo imaging properties of [11C] befloxatone: a novel highly potent positron emission tomography ligand for mono-amine oxidase-A F Dolle, H Valette, Y Bramoulle, I Guenther, C Fuseau, C Coulon, ... Bioorganic & medicinal chemistry letters 13 (10), 1771-1775, 2003 | 56 | 2003 |
| Ex Vivo Imaging of Pancreatic Beta Cells using a Radiolabeled GLP-1 Receptor Agonist BM Connolly, A Vanko, P McQuade, I Guenther, X Meng, D Rubins, ... Molecular Imaging and Biology 14, 79-87, 2012 | 55 | 2012 |
| Radiosynthesis and quality assurance of 5-[124I] iodo-2′-deoxyuridine for functional PET imaging of cell proliferation I Guenther, L Wyer, EJ Knust, RD Finn, J Koziorowski, R Weinreich Nuclear medicine and biology 25 (4), 359-365, 1998 | 51 | 1998 |
| Comparative Analysis of Folate Derived PET Imaging Agents with [18F]-2-Fluoro-2-deoxy-d-glucose Using a Rodent Inflammatory Paw Model SA Kularatne, MJ Bélanger, X Meng, BM Connolly, A Vanko, DL Suresch, ... Molecular Pharmaceutics 10 (8), 3103-3111, 2013 | 48 | 2013 |
| Mapping the cerebral monoamine oxidase type A: positron emission tomography characterization of the reversible selective inhibitor [11C] befloxatone M Bottlaender, F Dollé, I Guenther, D Roumenov, C Fuseau, Y Bramoulle, ... Journal of Pharmacology and Experimental Therapeutics 305 (2), 467-473, 2003 | 43 | 2003 |
| [76Br] Bromodeoxyuridine PET in tumor-bearing animals O Gardelle, U Roelcke, P Vontobel, NEA Crompton, I Guenther, ... Nuclear medicine and biology 28 (1), 51-57, 2001 | 37 | 2001 |
| Characterization of the nicotinic ligand 2-[18F] fluoro-3-[2 (S)-2-azetidinylmethoxy] pyridine in vivo H Valette, M Bottlaender, F Dollé, I Guenther, C Coulon, F Hinnen, ... Life sciences 64 (5), PL93-PL97, 1998 | 34 | 1998 |
| Synthesis of unlabelled, 3H‐ and 125I‐labelled β‐CIT and its ϖ‐fluoroalkyl analogues β‐CIT‐FE and β‐CIT‐FP, including synthesis of precursors CG Swahn, C Halldin, I Günther, J Patt, S Ametamey Journal of Labelled Compounds and Radiopharmaceuticals 38 (7), 675-685, 1996 | 30 | 1996 |
| Brain tumor iron uptake measured with positron emission tomography and 52Fe-citrate U Roelckel, KL Leenders, K Von Ammon, EW Radü, P Vontobel, I Günther, ... Journal of neuro-oncology 29, 157-165, 1996 | 23 | 1996 |
